Companies / Mira Pharmaceuticals, Inc.

Mira Pharmaceuticals, Inc.

Nasdaq: MIRACIK 1904286MIAMI, FL

Financials

Revenue—
Net income$-10.44M
Total debt—
Cash$3.61M
Diluted EPS$-1.35
Shares outstanding42.0M

Ownership

42.0M shares outstanding · as of Aug 10, 2026
8.5%Insiders
Ownership
Insiders8.55%3,592,666
Institutions5.61%2,356,678
Public float85.84%36,072,743

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Aminov ErezCEOCEO and Chairman · Director
8.55%3,592,666

Institutional holders 25

View all →
HolderValue% of shares
Vanguard Group Inc$997.4K1.57%
Cross Staff Investments Inc$542.7K0.86%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.$472.3K0.74%
Geode Capital Management, LLC$311.3K0.69%
BlackRock, Inc.$231.5K0.58%
Northern Trust Corp$102.2K0.16%
Suncoast Equity Management$97.0K0.22%
First American Bank$64.2K0.14%
International Assets Investment Management, LLC$52.9K0.08%
State Street Corporation$46.5K0.12%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon Stock$127.6K+135K
+122.85%
244,622
0.58% of shares
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
ExitCommon Stock$-40.8K-27K
-100.00%
0
low
Q1 2026
as of
AQR Capital Management, LLC
13F manager
ExitCommon Stock$-33.2K-22K
-100.00%
0
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$19.3K+18K
+6.60%
290,890
0.69% of shares
low
Q1 2026
as of
Suncoast Equity Management
13F manager
TrimCommon Stock$-13.5K-13K
-12.24%
90,645
0.22% of shares
low
Q4 2025
as of
Bank of America Corp /De
13F manager
AddCommon Stock$183+121
+86.43%
261
<0.01% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MIRACommon StockEquity60458C104BBG01H8XP5F5